Jim Simons Centogene N.V. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.06 - $4.25 $32,754 - $67,575	-15,900 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.3 - $5.44 $107,474 - $177,169	-32,568 Reduced 67.19%	15,900 $67,000
Q4 2021 Feb 11, 2022	SELL	$4.56 - $10.56 $35,257 - $81,649	-7,732 Reduced 13.76%	48,468 $253,000
Q3 2021 Nov 12, 2021	SELL	$9.9 - $11.72 $514,354 - $608,912	-51,955 Reduced 48.04%	56,200 $619,000
Q2 2021 Aug 13, 2021	BUY	$9.02 - $12.93 $544,862 - $781,049	60,406 Added 126.51%	108,155 $1.13 Million

Q1 2021 May 13, 2021	BUY	$10.56 - $13.94 $504,229 - $665,621	47,749 New	47,749 $579,000
Q3 2020 Nov 13, 2020	SELL	$9.3 - $25.16 $82,770 - $223,924	-8,900 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$15.99 - $22.88 $142,311 - $203,632	8,900 New	8,900 $204,000

2.14M

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $10.8M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.